Insights
Thought Leadership
GATC Health represents a collective of influential voices across a breadth of fields and professions. These are their directional stories and ideas.
Explore Platform Capabilities:
Chondrocyte and Mesenchymal Stem Cell–Based Regenerative Therapies for Osteoarthritis and Degenerative Bone Disorders
Mechanistic Artificial Intelligence for Personalized Drug Therapy: Integrating Pharmacokinetics, Pharmacodynamics, Therapeutic Drug Monitoring, and Multiomic Systems Biology
Coal Workers’ Pneumoconiosis in the 21st Century: Emerging Trends, Treatment Gaps, and Prognostic Uncertainties in a Resurgent Occupational Lung Disease
The Multi-Omics Profiling of Early-Passage Mesenchymal Stem Cell Exosomes Reveals Potential Targets for Attenuating Diabetic Inflammatory Pathophysiology
A Multi-Scale, Evidence-Orchestrated Digital Twin Architecture for Therapeutic Development: A Systems-Theoretic Framework
Advances in Clinical and Medical Research
Harnessing AI to Revolutionize Drug Discovery
Harnessing AI to Revolutionize Drug Discovery
Operon™ Platform–Enabled for Cardiometabolic Biomarker Screening and Precision Treatment Strategies: A Type 2 Diabetes–Centered Review with Cardiovascular Extension
Operon™ Platform–Enabled for Cardiometabolic Biomarker Screening and Precision Treatment Strategies: A Type 2 Diabetes–Centered Review with…
AI-Enabled Identification of Histaminergic Mechanisms Underlying Infusion-Related Dermatologic Reactions to a Targeted Oncolytic Peptide.
AI-Enabled Identification of Histaminergic Mechanisms Underlying Infusion-Related Dermatologic Reactions to a Targeted Oncolytic Peptide.
PNAS (Proceedings of the National Academy of Sciences): AI-derived therapeutic development of a serotonin receptor–targeting drug for the treatment of opioid use disorder
The opioid epidemic has led to a devastating loss of life nationwide. Of those dependent on opioids, many individuals desire to quit or red…
